Modular Medical (OTC:MODD – Get Rating) and Nemaura Medical (NASDAQ:NMRD – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, valuation, risk, institutional ownership, dividends and analyst recommendations.
Insider and Institutional Ownership
14.7% of Modular Medical shares are held by institutional investors. Comparatively, 3.4% of Nemaura Medical shares are held by institutional investors. 59.2% of Modular Medical shares are held by insiders. Comparatively, 41.5% of Nemaura Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Analyst Recommendations
This is a summary of recent ratings for Modular Medical and Nemaura Medical, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Modular Medical | 0 | 0 | 1 | 0 | 3.00 |
| Nemaura Medical | 0 | 0 | 2 | 0 | 3.00 |
Earnings & Valuation
This table compares Modular Medical and Nemaura Medical’s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Modular Medical | N/A | N/A | -$18.63 million | ($1.48) | -0.70 |
| Nemaura Medical | $500,000.00 | 38.15 | -$13.89 million | ($0.56) | -1.18 |
Nemaura Medical has higher revenue and earnings than Modular Medical. Nemaura Medical is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Modular Medical and Nemaura Medical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Modular Medical | N/A | -145.00% | -133.88% |
| Nemaura Medical | N/A | N/A | -75.78% |
Volatility and Risk
Modular Medical has a beta of 0.17, meaning that its stock price is 83% less volatile than the S&P 500. Comparatively, Nemaura Medical has a beta of -0.04, meaning that its stock price is 104% less volatile than the S&P 500.
Summary
Nemaura Medical beats Modular Medical on 7 of the 11 factors compared between the two stocks.
About Modular Medical
Modular Medical, Inc., a development stage medical device company, focuses on the design, development, and commercialization of insulin pumps using technology to enhance pump adoption in the diabetes marketplace. It also offers MODD1, a novel two-part patch pump. The company is headquartered in San Diego, California.
About Nemaura Medical
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.
Receive News & Ratings for Modular Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Modular Medical and related companies with MarketBeat.com's FREE daily email newsletter.
